| abstract |
The invention provides a method for diagnosing Alzheimer's Disease comprising detecting the amount of one or more polypeptides in a solubilised blood platelet polypeptide sample taken from a suspected Alzheimer's Disease sufferer and, if present, comparing the amount thereof with the amount of the polypeptide or polypeptides present in a corresponding sample taken from disease-free individuals. Significantly lowered amounts of said polypeptide or polypeptides in the sample, when compared to the amount in samples from disease-free individuals, being indicative of Alzheimer's Disease. |